Microfluidic-Based Holonomic Constraints of siRNA in the Kernel of Lipid/Polymer Hybrid Nanoassemblies for Improving Stable and Safe In Vivo Delivery
- 17 March 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 12 (13) , 14839-14854
Abstract
A safe and efficient delivery system is critical for clinical application of siRNA. However, the conventional electrostatic interaction-based siRNA nanoplexes with bulk mixing preparation were always unsatisfactory for its stability and safety. In this study, the new core-shell Lipid/PCL-PEI/siRNA nanoparticles (LPS NPs) endowing holonomic constraint of siRNA in the inner core were prepared by microfluidic technology. On the microfluidic chip, siRNAs were completely compressed into the inner hydrophilic core of reverse PCL-PEI micelles at a low N/P ratio of 5, followed by coating neutral lipid membrane to form core-shell nanoparticles, which had a uniform size (120.2±1.4 nm) and a negative charge (-8.8±1.6 mV). Compared to bulk mixing-based LMS NPs, the lower usage of cationic PCL-PEI materials and stronger protection of siRNA in serum were found in the microfluidic-based LPS NPs. Furthermore, it was demonstrated that the LPS NPs exhibited significant downregulation of EGFR mRNA and protein expression level both in vitro and in vivo, and showed significant inhibition of tumor growth following systemic administration along with no obvious systemic toxicity. These findings demonstrated that the microfluidic-based lipid/polymer hybrid nano-assembles would offer a promising siRNA delivery system for clinical application.Keywords
Funding Information
- Ministry of Science and Technology of the People's Republic of China (2018ZX09721003-004)
- National Natural Science Foundation of China (81473158, 81690264, 81773650)
This publication has 59 references indexed in Scilit:
- Multifunctional Envelope-Type siRNA Delivery Nanoparticle Platform for Prostate Cancer TherapyACS Nano, 2017
- Neuron-Targeted Nanoparticle for siRNA Delivery to Traumatic Brain InjuriesACS Nano, 2016
- RNAi Therapies: Drugging the UndruggableScience Translational Medicine, 2014
- Synergistic inhibition of breast cancer by co-delivery of VEGF siRNA and paclitaxel via vapreotide-modified core–shell nanoparticlesBiomaterials, 2014
- Gene delivery by lipoplexes and polyplexesEuropean Journal of Pharmaceutical Sciences, 2010
- Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticlesNature, 2010
- The Effect of Chemical Modification and Nanoparticle Formulation on Stability and Biodistribution of siRNA in MiceMolecular Therapy, 2009
- RNAi therapeutics: Principles, prospects and challengesAdvanced Drug Delivery Reviews, 2007
- RNA Interference: Biology, Mechanism, and ApplicationsMicrobiology and Molecular Biology Reviews, 2003
- Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegansNature, 1998